Skip to main content
OpenTrials

Clinical trial condition

HIV-1 Infection

Explore clinical trials studying HIV-1 Infection. Study availability and eligibility vary by location and protocol.

183 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HIV-1 Infection trial results

Active, not recruiting

Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)

NCT04776252

Conditions
HIV-1 Infection
Locations
  • Pueblo Family Physicians ( Site 0010) Phoenix, Arizona, United States
  • One Community Health ( Site 0045) Sacramento, California, United States
  • Whitman-Walker Institute ( Site 0039) Washington D.C., District of Columbia, United States
  • Georgetown University Medical Center-Clinical Trials Unit Division of Infectious Diseases ( Site 002 Washington D.C., District of Columbia, United States
View all 93 locations
View Trial Details
Active, not recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

NCT05631093

Conditions
HIV-1 Infection
Locations
  • Kaiser Permanente-Infectious Disease ( Site 3014) Los Angeles, California, United States
  • Palmtree Clinical Research ( Site 3032) Palm Springs, California, United States
  • Zuckerberg San Francisco General Hospital and Trauma Center-UCSF ID Clinical Trials Center ( Site 30 San Francisco, California, United States
  • Georgetown University Medical Center ( Site 3006) Washington D.C., District of Columbia, United States
View all 53 locations
View Trial Details
Active, not recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

NCT05630755

Conditions
HIV-1 Infection
Locations
  • Pueblo Family Physicians ( Site 1425) Phoenix, Arizona, United States
  • Pacific Oaks Medical Group ( Site 1400) Beverly Hills, California, United States
  • Ruane Clinical Research Group, Inc ( Site 1414) Los Angeles, California, United States
  • Mills Clinical Research ( Site 1433) Los Angeles, California, United States
View all 49 locations
View Trial Details
Active, not recruiting

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

NCT05705349

Conditions
HIV-1 Infection
Locations
  • Pueblo Family Physicians ( Site 5674) Phoenix, Arizona, United States
  • Pacific Oaks Medical Group ( Site 5681) Beverly Hills, California, United States
  • Ruane Clinical Research Group, Inc ( Site 5658) Los Angeles, California, United States
  • Vivent Health ( Site 5694) Denver, Colorado, United States
View all 131 locations
View Trial Details
Completed

Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)

NCT04233879

Conditions
HIV-1 Infection
Locations
  • University of Alabama at Birmingham 1917 Research Clinic ( Site 5610) Birmingham, Alabama, United States
  • Pueblo Family Physicians ( Site 5606) Phoenix, Arizona, United States
  • Ruane Clinical Research Group, Inc. ( Site 5624) Los Angeles, California, United States
  • Midway Immunology and Research ( Site 5622) Ft. Pierce, Florida, United States
View all 95 locations
View Trial Details
Completed

Renal Transplantation and Raltegravir in HIV-Infected Patients

NCT01453192

Conditions
Chronic Disease, Chronic Renal Insufficiency, Disease Attributes, +11 more
Locations
  • Hôpital Pellegrin, Service de Nephrologie, Transplantation Rénale, Dialyse Bordeaux, France
  • CHU De Caen, Service de Néphrologie Hémodialyse Caen, France
  • Hôpital Henri Mondor, Service de Néphrologie Transplantation Créteil, France
  • Hôpital Kremlin Bicêtre, Service de Néphrologie Le Kremlin-Bicêtre, France
View all 14 locations
View Trial Details
Completed

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

NCT04133012

Conditions
HIV-1 Infection
Locations
  • Antoine-Beclere Hospital Clamart, France
  • Bicetre Hospital Le Kremlin-Bicêtre, France
  • Saint Antoine Hospital Paris, France
  • Bichat Hospital Paris, France
View Trial Details

Related conditions